Cardiovascular: Clinical Trials

3 trials for Cardiovascular, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Not yet recruiting 1, Recruiting 1
Phase 21Recruiting 1

Follow Cardiovascular: new trials by email Literature Review of Cardiovascular trials Research Report on Cardiovascular

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Metformin, semaglutide, Anti-hypertensives - Menopause, Menopause Hot Flashes
Phase 2 / Phase 3RecruitingUniversity of Colorado, Denver2002026-03-012026-11-04
Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability
Bempedoic Acid 180 MG Oral Tablet, Rosuvastatin 5 mg, Placebo - Cardiovascular
Phase 3Not yet recruitingSohaib Ashraf6902025-11-102025-11-20
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
Ferric Citrate 1 GM Oral Tablet [AURYXIA], Placebo - Anemia, Iron Deficiency, Hyperphosphatemia
Phase 3CompletedUSRC Kidney Research2892022-03-302025-08-29

Narrower conditions

Anemia, Iron-Deficiency (1)  ·  Disease Progression (1)  ·  Hyperphosphatemia (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Anemia (1)  ·  Anemia, Hypochromic (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Iron Deficiencies (1)  ·  Iron Metabolism Disorders (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)

Interventions

8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid (1)  ·  Angiotensin Receptor Antagonists (1)  ·  Antihypertensive Agents (1)  ·  Metformin (1)  ·  Rosuvastatin Calcium (1)  ·  Tablets (1)  ·  ferric citrate (1)  ·  fezolinetant (1)  ·  semaglutide (1)

Sponsors

Sohaib Ashraf (1)  ·  USRC Kidney Research (1)  ·  University of Colorado, Denver (1)

Countries

United States (2)

Top investigators

Geoff Block, MD (1)  ·  Nanette Santoro, MD (1)